05:23 AM EDT, 06/18/2024 (MT Newswires) -- Keros Therapeutics ( KROS ) said late Monday that Chief Executive Officer Jasbir Seehra will take over as board chair from July 1.

The company said Carl Gordon, the current chair, will remain an "active" board member.

Additionally, Christopher Rovaldi has been promoted to president, effective July 1, and will also continue serving as the company's chief operating officer. Rovaldi succeeds Seehra as president.

Price: 44.16, Change: -0.42, Percent Change: -0.94